Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ 522.18M | $ 702.58M | $ 717.21M | $ 474.59M |
Total Assets | - | $ 1.67B | $ 1.80B | $ 1.95B | $ 1.89B |
Total Debt | $ ― | $ 132.11M | $ 251.80M | $ 338.63M | $ 338.76M |
Net Debt | $ ― | $ -390.07M | $ -450.77M | $ -378.58M | $ -135.84M |
Total Liabilities | - | $ 191.38M | $ 345.61M | $ 466.89M | $ 517.35M |
Stockholders Equity | $ ― | $ 1.48B | $ 1.45B | $ 1.48B | $ 1.37B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |